Your browser doesn't support javascript.
loading
Atomoxetine reverses locomotor hyperactivity, impaired novel object recognition, and prepulse inhibition impairment in mice lacking pituitary adenylate cyclase-activating polypeptide.
Shibasaki, Y; Hayata-Takano, A; Hazama, K; Nakazawa, T; Shintani, N; Kasai, A; Nagayasu, K; Hashimoto, R; Tanida, M; Katayama, T; Matsuzaki, S; Yamada, K; Taniike, M; Onaka, Y; Ago, Y; Waschek, J A; Köves, K; Reglodi, D; Tamas, A; Matsuda, T; Baba, A; Hashimoto, H.
  • Shibasaki Y; Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka 565-0871, Japan.
  • Hayata-Takano A; Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka 565-0871, Japan; Molecular Research Center for Children's Mental Development, United Graduate School of Child Development, Osaka University, Kanazawa University, Hamamatsu University
  • Hazama K; Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka 565-0871, Japan.
  • Nakazawa T; iPS Cell-based Research Project on Brain Neuropharmacology and Toxicology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka 565-0871, Japan.
  • Shintani N; Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka 565-0871, Japan.
  • Kasai A; Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka 565-0871, Japan.
  • Nagayasu K; iPS Cell-based Research Project on Brain Neuropharmacology and Toxicology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka 565-0871, Japan.
  • Hashimoto R; Molecular Research Center for Children's Mental Development, United Graduate School of Child Development, Osaka University, Kanazawa University, Hamamatsu University School of Medicine, Chiba University and University of Fukui, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan; Department of Psychiatry, G
  • Tanida M; Department of Physiology II, Kanazawa Medical University, Uchinada, Kahoku, Ishikawa 920-0293, Japan.
  • Katayama T; Molecular Brain Science, United Graduate School of Child Development, Osaka University, Kanazawa University, Hamamatsu University School of Medicine, Chiba University and University of Fukui, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan.
  • Matsuzaki S; Molecular Research Center for Children's Mental Development, United Graduate School of Child Development, Osaka University, Kanazawa University, Hamamatsu University School of Medicine, Chiba University and University of Fukui, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan; Molecular Brain Science, Un
  • Yamada K; Research Center for Child Mental Development, Hamamatsu University School of Medicine, Hamamatsu 431-3192, Japan.
  • Taniike M; Molecular Research Center for Children's Mental Development, United Graduate School of Child Development, Osaka University, Kanazawa University, Hamamatsu University School of Medicine, Chiba University and University of Fukui, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan; Department of Pediatrics, G
  • Onaka Y; Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka 565-0871, Japan; Laboratory of Medicinal Pharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka 565-0871, Japan.
  • Ago Y; Laboratory of Medicinal Pharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka 565-0871, Japan; Semel Institute for Neuroscience and Human Behavior, Intellectual Development and Disabilities Research Center, The David Geffen School of Medicine, University of Califor
  • Waschek JA; Semel Institute for Neuroscience and Human Behavior, Intellectual Development and Disabilities Research Center, The David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
  • Köves K; Department of Human Morphology and Developmental Biology, Semmelweis University, Tuzoltó utca 58, 1094 Budapest, Hungary.
  • Reglodi D; Department of Anatomy, PTE-MTA "Lendulet" PACAP Research Team, Medical School, University of Pecs, Szigeti 12, 7624 Pecs, Hungary.
  • Tamas A; Department of Anatomy, PTE-MTA "Lendulet" PACAP Research Team, Medical School, University of Pecs, Szigeti 12, 7624 Pecs, Hungary.
  • Matsuda T; Molecular Research Center for Children's Mental Development, United Graduate School of Child Development, Osaka University, Kanazawa University, Hamamatsu University School of Medicine, Chiba University and University of Fukui, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan; Laboratory of Medicinal Pha
  • Baba A; School of Pharmacy, Hyogo University of Health Sciences, Chuo-ku, Kobe, Hyogo 650-8530, Japan.
  • Hashimoto H; Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka 565-0871, Japan; Molecular Research Center for Children's Mental Development, United Graduate School of Child Development, Osaka University, Kanazawa University, Hamamatsu University
Neuroscience ; 297: 95-104, 2015 Jun 25.
Article en En | MEDLINE | ID: mdl-25841321

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trastornos del Conocimiento / Inhibidores de Captación Adrenérgica / Polipéptido Hipofisario Activador de la Adenilato-Ciclasa / Inhibición Prepulso / Clorhidrato de Atomoxetina / Hipercinesia / Trastornos de la Memoria Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Animals Idioma: En Año: 2015 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trastornos del Conocimiento / Inhibidores de Captación Adrenérgica / Polipéptido Hipofisario Activador de la Adenilato-Ciclasa / Inhibición Prepulso / Clorhidrato de Atomoxetina / Hipercinesia / Trastornos de la Memoria Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Animals Idioma: En Año: 2015 Tipo del documento: Article